Choice of Outcome Measure in an Economic Evaluation: A Potential Role for the Capability Approach
- 372 Downloads
The last decade has seen a renewed interest in Sen’s capability approach; health economists have been instrumental in leading much of this work. One particular stream of research is the application of the approach to outcome measurement. To date, there have been a dozen attempts (some combined) to operationalise the approach, and produce an outcome measure that offers a broader evaluative space than health-related quality-of-life measures. Applications have so far been confined to public health, physical, mental health and social care interventions, but the capability approach could be of benefit to evaluations of pharmacotherapies and other technologies. This paper provides an introduction to the capability approach, reviews the measures that are available for use in an economic evaluation, including their current applications, and then concludes with a discussion of a number of issues that require further consideration before the approach is adopted more widely to inform resource allocation decisions.
KeywordsHealth Technology Assessment Social Care Aflibercept Capability Approach Lisdexamfetamine
The author would like to acknowledge the ICECAP team, particularly Prof. Joanna Coast and Dr Philip Kinghorn, for providing an anonymised registry of trials and studies that are using the ICECAP instruments. The author has no conflicts of interest.
- 1.Stoddart A, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, Sheikh A, Krishan A, Padfield P, McKinstry B. Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial. BMJ Open. 2013; 3(5).Google Scholar
- 11.Sen A. Commodities and capabilities. New York: Elsevier; 1985.Google Scholar
- 12.Sen A. Capability and well-being. In: Sen A, Nussbaum MC, editors. The quality of life. Oxford: Claredon Press; 1993.Google Scholar
- 19.Sugden R. Welfare, resources, and capabilities: a review of inequality reexamined by Amartya Sen. J Econ Lit. 1993;31(4):1947–62.Google Scholar
- 23.Lorgelly P, Lorimer K, Fenwick E, Briggs A. The capability approach: developing an instrument for evaluating public health interventions. Section of Public Health and Health Policy, University of Glasgow; 2008. http://www.gcph.co.uk/assets/0000/0430/Capabilities_-_full_report__August_08.pdf.
- 25.Teerawattananon Y, Yamabhai I, Leelahavarong P. Using capability index to determine a value for money of the AIDS competence process in Thailand. Research Report, Health Intervention and Technology Assessment Program (HITAP), Thailand. 2011. http://aidscompetence.ning.com/forum/attachment/download?id=2028109%3AUploadedFile%3A122912.
- 27.Vergunst F, Jenkinson C, Burns T, Simon J. Application of Sen’s capability approach to outcome measurement in mental health research: psychometric validation of a novel multi-dimensional instrument (OxCAP-MH). Hum Welf. 2014;3:1–4.Google Scholar
- 28.Greco G. Assessing women’s quality of life in rural malawi: a capabilities index. PhD Thesis, London School of Hygiene and Tropical Medicine. 2013.Google Scholar
- 38.Davis JC, Bryan S, McLeod R, Rogers J, Khan K, Liu-Ambrose T. Exploration of the association between quality of life, assessed by the EQ-5D and ICECAP-O, and falls risk, cognitive function and daily function, in older adults with mobility impairments. BMC Geriatrics. 2012;12(1):65.PubMedCentralPubMedCrossRefGoogle Scholar
- 39.Makai P, Looman W, Adang E, Melis R, Stolk E, Fabbricotti I. Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter? Eur J Health Econ. 2014. doi: 10.1007/s10198-014-0583-7
- 40.Jones C, Edwards RT, Hounsome B. Qualitative exploration of the suitability of capability based instruments to measure quality of life in family carers of people with dementia. ISRN Fam Med. 2014;2014:9.Google Scholar
- 41.EU Clinical Trials Register. Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (CLARITY). EudraCT number: 2013-003272-12. 2014. Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003272-12/GB.
- 42.NIHR HTA programme. The PRE-EMPT Trial: Preventing REcurrance of Endometriosis by Means of long acting Progestogen Therapy, Protocol, NIHR Health Technology Assessment Programme HTA, no: 11/114; 2013.Google Scholar
- 43.Malley J, Netten A. Measuring outcomes of social care. Res Policy Plan. 2009;27(2):85–96.Google Scholar
- 47.National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE; 2008.Google Scholar
- 48.National Institute for Health and Care Excellence. Methods for the development of NICE public health guidance. 3rd ed. London: NICE; 2012.Google Scholar
- 51.Fletcher J, Wolfe B. Long-term consequences of childhood ADHD on criminal activities. J Mental Health Policy Econ. 2009;12(3):119.Google Scholar
- 54.Henderson C, Knapp M, Fernández J-L, Beecham J, Hirani SP, Cartwright M, Rixon L, Beynon M, Rogers A, Bower P. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ. 2013;346:f1035.PubMedCrossRefGoogle Scholar
- 55.Davis JC, Bryan S, Marra CA, Sharma D, Chan A, Beattie BL, Graf P, Liu-Ambrose T. An economic evaluation of resistance training and aerobic training versus balance and toning exercises in older adults with mild cognitive impairment. PLoS One. 2013;8(5):e63031.PubMedCentralPubMedCrossRefGoogle Scholar
- 56.Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess. 2015; 19(14).Google Scholar
- 57.Sen AK. Choice, welfare and measurement. Cambridge: Harvard University Press; 1997.Google Scholar
- 58.Mitchell P, Roberts T, Barton P, Coast J. Applying the sufficient capability approach in health economic evaluations. In: presented at the Health Economists’ Study Group: Exeter. 2013.Google Scholar
- 59.Netten A, Beadle-Brown J, Caiels J, Forder J, Malley J, Smith N, Towers A-M. ASCOT: adult social care outcomes toolkit. Main guidance v2.1. In: PSSRU discussion paper 2716/3. 2011.Google Scholar
- 62.Lorgelly P. Cultural adaptation and capability instruments: more than translation and re-valuation. In: presented at the 3rd ICECAP Users Group Workshop: Birmingham. 2014.Google Scholar